Cargando…

Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2

We lack a correlate of immunity to herpes simplex virus 2 (HSV-2) that may be used to differentiate whether a HSV-2 vaccine elicits robust or anemic protection against genital herpes. This gap in knowledge is often attributed to a failure to measure the correct component of the adaptive immune respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halford, William P., Geltz, Joshua, Gershburg, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675040/ https://www.ncbi.nlm.nih.gov/pubmed/23755244 http://dx.doi.org/10.1371/journal.pone.0065523

Ejemplares similares

Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine
por: Geltz, Joshua J., et al.
Publicado: (2015)

Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
por: Joyce, Jonathan D., et al.
Publicado: (2021)

The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions
por: Gershburg, Svetlana, et al.
Publicado: (2015)

A System for Creating Stable Cell Lines that Express a Gene of Interest from a Bidirectional and Regulatable Herpes Simplex Virus Type 1 Promoter
por: Chambers, Christopher B., et al.
Publicado: (2015)

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2
por: Halford, William P., et al.
Publicado: (2015)

Virus-Specific Immune Memory at Peripheral Sites of Herpes Simplex Virus Type 2 (HSV-2) Infection in Guinea Pigs
por: Xia, Jingya, et al.
Publicado: (2014)

A Live-Attenuated HSV-2 ICP0 (−) Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
por: Halford, William P., et al.
Publicado: (2011)

Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
por: Brans, Richard, et al.
Publicado: (2010)

IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections
por: Wang, Ying-Ying, et al.
Publicado: (2014)

An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
por: Wan, Mingming, et al.
Publicado: (2023)

A Herpes Simplex Virus 2 (HSV-2) Glycoprotein D-expressing Nonreplicating Dominant-Negative HSV-2 Virus Vaccine Is Superior to a gD2 Subunit Vaccine against HSV-2 Genital Infection in Guinea Pigs
por: Zhang, Pengwei, et al.
Publicado: (2014)

Herpes simplex virus binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition
por: Schroeder, Holly A., et al.
Publicado: (2018)

Recurrent Herpes Simplex Virus 2 Lymphocytic Meningitis in Patient with IgG Subclass 2 Deficiency
por: Goyal, Tanvi, et al.
Publicado: (2020)

ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene
por: Liu, Mingyu, et al.
Publicado: (2010)

Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment
por: Patel, Eshan U., et al.
Publicado: (2015)

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
por: Egan, Kevin, et al.
Publicado: (2020)

Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
por: Stanfield, Brent A., et al.
Publicado: (2021)

Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment
por: Patel, Eshan U., et al.
Publicado: (2017)

Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis Among Sheltered Homeless Adults in Tehran, 2012
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2017)

Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development
por: Galli, Jennifer D., et al.
Publicado: (2022)

False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity
por: Vandervore, Laura, et al.
Publicado: (2022)

Pneumomediastinum and Pneumothorax Associated with Herpes Simplex Virus (HSV) Pneumonia
por: López-Rivera, Fermín, et al.
Publicado: (2018)

Herpes simplex virus 2 (HSV-2) evolves faster in cell culture than HSV-1 by generating greater genetic diversity
por: López-Muñoz, Alberto Domingo, et al.
Publicado: (2021)

A case of hypertrophic herpes simplex virus affecting the eyelid and cornea masquerading as IgG4-related disease
por: Dua, Prachi, et al.
Publicado: (2017)

Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs
Publicado: (1995)

1410. Neonatal Herpes Simplex Virus (HSV) Infection: Is It the Only Pathogen?
por: Dendi, Alvaro, et al.
Publicado: (2020)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
por: Casto, Amanda M., et al.
Publicado: (2020)

Passive transfer of autoimmune disease with isologous IgG1 and IgG2 antibodies to the tubular basement membrane in strain XIII guinea pigs: loss of self-tolerance induced by autoantibodies
Publicado: (1977)

Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens
por: Granato, Paul A., et al.
Publicado: (2015)

Assessment of IgG Antibodies Against HSV1, HSV2, CMV and EBV in Patients with Pemphigus Vulgaris Versus Healthy People
por: Ghalayani, Parichehr, et al.
Publicado: (2015)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Disseminated Herpes Simplex Virus-2 (HSV-2) as a Cause of Viral Hepatitis in an Immunocompetent Host
por: Srinivasan, Dushyanth, et al.
Publicado: (2021)

Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells
por: Panteva, M., et al.
Publicado: (1998)

Seroprovalence of herpes simplex1, 2 IgG antibodies in patients with beta thalassemia in a major tertiary care hospital located in Yazd, Iran
por: Atefi, A, et al.
Publicado: (2014)

False Positive PCR for Herpes Simplex Virus (HSV) in Childhood CNS Infections
por: Sasan, M S
Publicado: (2012)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Correction: Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells
por: Panteva, M., et al.
Publicado: (1998)

Persistence of mucosal T cell responses to herpes simplex virus type 2 (HSV-2) in the female genital tract
por: Posavad, Christine M., et al.
Publicado: (2014)

No Role of Herpes Simplex Virus Type 2 (HSV-2) Infection on HIV Progression in Naïve HIV Patients
por: Mohraz, Minoo, et al.
Publicado: (2018)

Urea dilution of serum for reproducible anti-HSV1 IgG avidity index
por: Olsson, Jan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_653842dv1ke7folp6ldthcujk3